Jazz Pharmaceuticals plc (JAZZ)

Nasdaq · Healthcare · Biotechnology
$230.26-2.62%As of 2026-11-22 · USD
Last session low $227.95Last session high $238.59
52-week low $156.9552-week high $266.38
Market cap
$14.78B
Sector
Healthcare
P/E (TTM)
68.1x

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)48.0In the neutral range (30 to 70)
MACD (12, 26, 9)4.31Above its signal line (3.99); histogram 0.32
Bollinger %B (20, 2)51%Inside the bands (200.45 to 259.08)
SMA 20229.76Price is 0.2% above
SMA 50228.72Price is 0.7% above
SMA 200221.86Price is 3.8% above
ATR (20)3.36% of priceAverage true range per day
52-week position67%In the upper part of the 156.95 to 266.38 range

About Jazz Pharmaceuticals plc

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.

Insider filings, 90 daysNo purchases and 10 sales (about $41.4M).
Latest fiscal yearEnded 2025-12-31: revenue of $4.27B and an operating margin of 12.1%.

More in Biotechnology